Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
YEP KC teen serves hope through enterprising volleyball benefit for men’s shelter
When 17-year-old Catherine Franano learned the mattresses at Kansas City Rescue Mission were old and too worn for comfortable use, the Pembroke High School senior leapt into action, she said. “Some of these people … like they’ve just had so many awful things happen to them, but not having anywhere to sleep?” Catherine said. “How…
(Video) ESHIP Summit attendees ask: Can entrepreneurial support efforts actually be sustainable?
When more than 600 attendees gathered this week in Kansas City for the second ESHIP Summit, they each came with their own ecosystems, businesses, local governments and support networks in mind. They also brought questions. “What are they doing in their cities? What’s worked and what hasn’t worked? What can we adopt back at home…
Four key moments led to SoftVu’s exit (three missteps kept it from happening sooner)
Deals like the acquisition of KC-based SoftVu by an Alabama private equity firm don’t happen overnight. And founder Tim Donnelly gives near-equal weight to the trials and triumphs that led the marketing platform to its big exit. “We’ve done as much as we possibly can based on the mistakes we’ve made, the lessons that have…
Eyeing added impact, AltCap expands its KC service area
AltCap — a Kansas City-based community development financial institution that focuses on underserved populations — is expanding its footprint. In response to small businesses’ growing demand for capital, AltCap will now serve the entire Kansas City metro, including the Kansas counties of Wyandotte, Johnson, and Leavenworth. The move will allow AltCap to finance more small…